Related Experiment Video
Updated: Jun 24, 2026
08:29
Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA
Published on: February 1, 2019
Optimization and characterization of anionic lipoplexes for gene delivery.
Charudharshini Srinivasan1, Diane J Burgess
1Department of Pharmaceutical Sciences, University of Connecticut, 69 North Eagleville Road, Unit 3092, Storrs, CT 06269, USA. csrinivasan@idi.harvard.edu
Summary
Optimized anionic lipoplexes, using calcium and specific lipids, achieve high DNA transfection efficiency (78%) with minimal cell toxicity (93% viability). This non-viral vector outperforms commercial alternatives.
Area of Science:
- Biotechnology
- Gene Delivery
- Nanomedicine
Background:
- Non-viral gene delivery vectors are crucial for therapeutic applications.
- Developing efficient and safe gene delivery systems remains a significant challenge.
- Anionic lipoplexes offer potential as an alternative to viral vectors.
Purpose of the Study:
- To optimize anionic lipoplex formulations for enhanced gene transfection efficiency.
- To minimize cytotoxicity associated with lipoplex-based gene delivery.
- To characterize the biophysical properties and cellular uptake of optimized lipoplexes.
Main Methods:
- Systematic variation of lipid ratios (DOPG:DOPE), cation types (Ca2+, Mg2+, Na+), and lipid/DNA ratios.
- Biophysical characterization using particle size analysis, gel electrophoresis, and transmission electron microscopy (TEM).
- Assessment of cellular uptake via confocal microscopy and evaluation of transfection efficiency and cell viability (MTT assay).
Main Results:
- An optimized formulation (1:4 DOPG:DOPE, 15-20 mM Ca2+, 15-20 µg lipid/0.8 µg DNA) demonstrated high transfection efficiency (~78%) and cell viability (~93%).
- TEM revealed structural differences, gel electrophoresis confirmed lipoplex formation with minimal free DNA, and confocal imaging showed cellular uptake.
- The optimized anionic lipoplex significantly outperformed Lipofectamine 2000 in both transfection efficiency (~68%) and cell viability (~35%).
Conclusions:
- The developed anionic lipoplex formulation exhibits superior performance compared to a commercial standard.
- This formulation represents a promising non-viral vector for gene delivery, balancing high transfection efficiency with low cytotoxicity.
- Further development of these anionic lipoplexes could advance gene therapy applications.
